Literature DB >> 23764467

Autonomic dysfunction in parkinsonian LRRK2 mutation carriers.

Beatriz Tijero1, Juan Carlos Gómez Esteban, Johanne Somme, Verónica Llorens, Elena Lezcano, Ana Martinez, Trinidad Rodríguez, Koldo Berganzo, Juan José Zarranz.   

Abstract

INTRODUCTION: The aim of this study was to compare autonomic function in PD symptomatic carriers of the LRRK2 mutations and idiopathic Parkinson's disease (iPD) patients.
MATERIAL AND METHODS: We studied 25 PD patients: 12 with the LRRK2 mutation (6 G2019S and 6 R1441G), and 13 with iPD. All patients underwent blood pressure and heart rate monitoring during head up tilt, Valsalva maneuver and deep breathing, along with recording of sympathetic skin response (SSR) and cardiac MIBG scintigraphy.
RESULTS: Three of the patients with iPD and one of the LRRK2 carriers had orthostatic hypotension. Arterial pressure "overshoot" during phase IV of Valsalva maneuver was less pronounced in patients with iPD. During passive tilt, LRRK2 carries had higher increase of blood pressure than iPD patients MIBG late myocardial/mediastinal uptake ratios were higher in LRRK2 mutation carriers (1.51 ± 0.28 vs 1.32 ± 0.25; p < 0.05). DISCUSSION: Carriers of the LRRK2 mutation had less autonomic impairment than those with iPD as shown by higher cardiac MIBG uptake and a tendency to less impairment of autonomic non-invasive tests. It is important to carry out larger studies comparing the clinical, functional and pathological characteristics of these patients.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autonomic disorders; LRRK2 gene; Parkinson's disease

Mesh:

Substances:

Year:  2013        PMID: 23764467     DOI: 10.1016/j.parkreldis.2013.05.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

1.  A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis.

Authors:  Nir Giladi; Anat Mirelman; Avner Thaler; Avi Orr-Urtreger
Journal:  Front Neurol       Date:  2016-05-10       Impact factor: 4.003

Review 2.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

3.  Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.

Authors:  Claudia Carricarte Naranjo; Connie Marras; Naomi P Visanji; David J Cornforth; Lazaro Sanchez-Rodriguez; Birgitt Schüle; Samuel M Goldman; Mario Estévez; Phyllis K Stein; Anthony E Lang; Herbert F Jelinek; Andrés Machado
Journal:  Clin Auton Res       Date:  2019-08-23       Impact factor: 4.435

4.  Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.

Authors:  Iñigo Gabilondo; Verónica Llorens; Trinidad Rodriguez; Manuel Fernández; Tomas Pérez Concha; Marian Acera; Beatriz Tijero; Ane Murueta-Goyena; Rocío Del Pino; Jesús Cortés; Juan Carlos Gómez-Esteban
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-15       Impact factor: 9.236

5.  Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.

Authors:  Taku Hatano; Manabu Funayama; Shin-Ichiro Kubo; Ignacio F Mata; Yutaka Oji; Akio Mori; Cyrus P Zabetian; Sarah M Waldherr; Hiroyo Yoshino; Genko Oyama; Yasushi Shimo; Ken-Ichi Fujimoto; Hirokazu Oshima; Yasuto Kunii; Hirooki Yabe; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Neurobiol Aging       Date:  2014-06-02       Impact factor: 4.673

6.  Clinical Heterogeneity Among LRRK2 Variants in Parkinson's Disease: A Meta-Analysis.

Authors:  Li Shu; Yuan Zhang; Hongxu Pan; Qian Xu; Jifeng Guo; Beisha Tang; Qiying Sun
Journal:  Front Aging Neurosci       Date:  2018-09-19       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.